Articles related to SCHIZOPHRENIA

Ulotaront’s failure to meet its primary endpoint in recent phase 3 trials raises questions about the drug’s future and emphasizes the need for more effective treatments in the field of schizophrenia.

New research identifies the placenta as a significant factor in schizophrenia risk, revealing more than 100 genes that impact the disorder and suggesting new avenues for prevention and treatment.

This case study highlights the critical role of vitamin B12 testing in diagnosing and treating neuropsychiatric disorders, urging physicians to consider this simple yet often overlooked test.

This case study reveals the ethical and medical dilemmas that can arise from non-disclosure of mental health conditions in postpartum care. Learn how this lack of transparency impacted both the patient and her newborn, and what it means for medical ethics and patient safety.

Explore the clinical insights into lumateperone, a second-generation antipsychotic showing promise in treating schizophrenia, and learn how understanding effect sizes can guide your treatment decisions.

Enhance your clinical acumen in managing acute agitation in schizophrenia and bipolar disorder patients. Equip yourself with the latest guidelines and treatment options to provide optimal care in emergency settings.